CD8A and malignant colon neoplasm: Having demonstrated that the combination of PDT and immunostimulatory NPs reduced the tumor burden of colon cancers in vivo, in a CD8+ T cell-dependent manner, we further investigated the anti-tumor immune response elicited by this treatment, by analyzing diverse immune cell populations present in the tumor microenvironment and secondary lymphoid organs.